In 2011, spending on the Brazilian healthcare market reached US $222.71 billion, with an expected compound annual growth rate (CAGR) of 8.6% during 2012-2015, to reach $355.14 billion in value at consumer prices.
The main factors behind the high healthcare expenditure include the prevalence of various diseases in the country. Almost one-fourth of the population is suffering from hypertension.
Among the Brazilian healthcare sectors, the pharmaceutical market in the country is witnessing tremendous growth. Brazil's pharmaceutical market is ranked as the number one in Latin America, boasting a market share of 38% and a market value of $25.60 billion in 2011. The sector that experienced the most success within the pharmaceutical market in 2011 was the generics market which witnessed more than 40% growth against the previous year.
In 1988, Brazil created the Sistema Único de Saúde (SUS), which guarantees healthcare for everybody under the terms of its constitution. The SUS has more than 70,000 ambulatory units, 7,000 hospitals (private and public) and holds more than 400 million consultations per year, including 100 million with a specialist, seeing mostly chronic patients.
Government expenditure on the Brazilian healthcare market, which accounted for 46.4% of total health expenditure in 2010, is forecast to increase in relative terms to 50.27% of total healthcare spending by 2015.
Two major reasons for this can be attributed to the fact that Brazil will stage the 2014 World Cup and 2016 Olympics, both of which represent a strong growth in infrastructure investment ($200 billion).
For more information on the Brazilian healthcare market, see the latest research: Brazilian Healthcare Market Report
Follow us on Twitter @CandMResearch
Companiesandmarkets.com issues news updates and report summaries covering all major industries and sectors. The service provides additional client monitoring and timely alerts to breaking industry and sector news leading the day's business headlines. News articles, written by our staff, contain additional analyst insight, providing value added insight for our readers. News updates and real-time alerts on newly-released market reports are also available from our Facebook page, Twitter feed @CandMResearch and RSS links. We also welcome inquiries from business journalists and the news media.